Ticker Scorecard - PHAT Basics Company: Phathom Pharmaceuticals, Inc. IPO Date: October 21, 2019 Sector: Healthcare Industry: Biotech Market Cap: $387.7M Activated in VL: True Average Daily Range Avg Daily Range: $0.67 | 3.44% Avg Daily Range (30 D): $0.20 | 3.18% Avg Daily Range (90 D): $0.42 | 3.93% Institutional Daily Volume Avg Daily Volume: .31M Avg Daily Volume (30 D): .89M Avg Daily Volume (90 D): 1.05M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 93 Avg Trade Size (Sh.) (90 D): 92 Institutional Trades Total Inst.Trades: 627 Avg Inst. Trade: $1.5M Avg Inst. Trade (30 D): $.77M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.53M Avg Closing Trade (30 D): $.62M Avg Closing Trade (90 D): $1.12M Avg Closing Volume: 98.61K     News Jan 29, 2025 @ 1:00 PM Phathom Pharmaceuticals to Present at the Guggenhe... Source: N/A Oct 28, 2024 @ 12:00 PM Phathom Pharmaceuticals to Report Third Quarter 20... Source: N/A Aug 21, 2024 @ 7:16 PM The Top 3 Most-Shorted Stocks in August Source: The Tokenist Aug 8, 2024 @ 12:00 PM Phathom Pharmaceuticals Reports Second Quarter 202... Source: N/A Jun 23, 2024 @ 10:52 AM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast Financials   TTM Q3 2024 Q2 2024 Basic EPS $-5.75 $-1.32 $-1.56 Diluted EPS $-5.75 $-1.32 $-1.56 Revenue $ 26.27M $ 16.35M $ 7.32M Gross Profit $ 21.95M $ 14M $ 5.95M Net Income / Loss $ -339.45M $ -85.58M $ -91.45M Operating Income / Loss $ -287.93M $ -70.8M $ -77.3M Cost of Revenue $ 4.33M $ 2.36M $ 1.38M Net Cash Flow $ 121.01M $ 58.44M $ -46M PE Ratio